NEW YORK, April 14, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Babcock & Wilcox Enterprises, Inc. securities (NYSE: BW) from July 1, 2015 through February 28, 2017, inclusive (the “Class Period”) of the important May 2, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Babcock & Wilcox investors under the federal securities laws.
To join the Babcock & Wilcox class action, go to http://www.rosenlegal.com/cases-1065.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
The complaint alleges that defendants during the Class Period made false and misleading statements and/or failed to disclose that: (1) Babcock & Wilcox’s Renewable business had productivity and scheduling issues; (2) these undisclosed problems decreased profit margins and worsened financial performance; (3) Babcock & Wilcox’s Renewable business suffered from problematic on-site project management and a lack of resources in engineering and project management groups, which resulted in overly aggressive project bidding, project delays, and engineering errors; (4) Babcock & Wilcox lacked adequate project management processes in its Renewable business, which negatively impacted performance on key projects from bidding through execution; (5) as a result, defendants’ statements regarding Babcock & Wilcox’s outlook and expected financial performance were false and misleading and lack a reasonable basis when made. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 2, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1065.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
U.S. Lawmakers Raise Alarm Over Trump Approval of Nvidia AI Chip Sales to China
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Google Seeks Delay on Data-Sharing Order as It Appeals Landmark Antitrust Ruling
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 



